TY  - GEN
AU  - Swisher,Elizabeth M
AU  - Lin,Kevin K
AU  - Oza,Amit M
AU  - Scott,Clare L
AU  - Giordano,Heidi
AU  - Sun,James
AU  - Konecny,Gottfried E
AU  - Coleman,Robert L
AU  - Tinker,Anna V
AU  - O'Malley,David M
AU  - Kristeleit,Rebecca S
AU  - Ma,Ling
AU  - Bell-McGuinn,Katherine M
AU  - Brenton,James D
AU  - Cragun,Janiel M
AU  - Oaknin,Ana
AU  - Ray-Coquard,Isabelle
AU  - Harrell,Maria I
AU  - Mann,Elaina
AU  - Kaufmann,Scott H
AU  - Floquet,Anne
AU  - Leary,Alexandra
AU  - Harding,Thomas C
AU  - Goble,Sandra
AU  - Maloney,Lara
AU  - Isaacson,Jeff
AU  - Allen,Andrew R
AU  - Rolfe,Lindsey
AU  - Yelensky,Roman
AU  - Raponi,Mitch
AU  - McNeish,Iain A
TI  - Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
SN  - 1474-5488
PY  - 2017///0613
KW  - Aged
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - BRCA1 Protein
KW  - genetics
KW  - BRCA2 Protein
KW  - Carcinoma, Ovarian Epithelial
KW  - Drug Resistance, Neoplasm
KW  - drug effects
KW  - Fallopian Tube Neoplasms
KW  - drug therapy
KW  - Female
KW  - Follow-Up Studies
KW  - Germ-Line Mutation
KW  - Humans
KW  - Indoles
KW  - therapeutic use
KW  - International Agencies
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Neoplasm Staging
KW  - Neoplasms, Glandular and Epithelial
KW  - Ovarian Neoplasms
KW  - Peritoneal Neoplasms
KW  - Platinum
KW  - Poly(ADP-ribose) Polymerase Inhibitors
KW  - Poly(ADP-ribose) Polymerases
KW  - chemistry
KW  - Prognosis
KW  - Prospective Studies
KW  - Salvage Therapy
KW  - Survival Rate
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1016/S1470-2045(16)30559-9
ER  -